Zim Laboratories Ltd has reported Consolidated financial results for the period ended June 30, 2024.
Financial Results (Q1 FY2025) - QoQ Comparison
The company has reported total income of Rs. 82.8233 crores during the period ended June 30, 2024 as compared to Rs. 119.3975 crores during the period ended March 31, 2024.
The company has posted net profit / (loss) of Rs. 0.8983 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs. 8.0857 crores for the period ended March 31, 2024.
The company has reported EPS of Rs. 0.18 for the period ended June 30, 2024 as compared to Rs. 1.66 for the period ended March 31, 2024.
| Total Income | ₹ 82.8233 crs | ₹119.3975 crs |  -30.63% | | Net Profit | ₹0.8983 crs | ₹8.0857 crs | -88.89% | | EPS | ₹0.18 | ₹1.66 | -89.16% |
Financial Results (Q1 FY2025) - YoY Comparison
The company has reported total income of Rs. 82.8233 crores during the period ended June 30, 2024 as compared to Rs.68.5583 crores during the period ended June 30, 2023.
The company has posted net profit / (loss) of Rs.0.8983 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs.0.2266 crores for the period ended June 30, 2023.
The company has reported EPS of Rs.0.18 for the period ended June 30, 2024 as compared to Rs.0.05 for the period ended June 30, 2023.
| Total Income | ₹ 82.8233 crs | ₹68.5583 crs |  20.81% | | Net Profit | ₹0.8983 crs | ₹0.2266 crs | 296.43% | | EPS | ₹0.18 | ₹0.05 | 260.00% |
Shares of Zim Laboratories Ltd was last trading in BSE at Rs. 113.90 as compared to the previous close of Rs. 114.25. The total number of shares traded during the day was 5426 in over 145 trades.
The stock hit an intraday high of Rs. 114.35 and intraday low of 112.30. The net turnover during the day was Rs. 615964.00. |
